Oxygen Therapy

Oxygen therapy is a fundamental supportive treatment in veterinary medicine used to increase the amount of oxygen available to dogs experiencing hypoxemia, respiratory distress, or any condition that impairs the body's ability to obtain adequate oxygen from breathing normal room air. Unlike pharmaceutical drugs that work through biochemical mechanisms, supplemental oxygen acts by simply increasing the concentration of oxygen in the inspired air, allowing more oxygen molecules to reach the lungs and transfer into the bloodstream with each breath. This therapy is considered a cornerstone of emergency and critical care medicine, providing essential life support while the underlying cause of respiratory compromise is diagnosed and treated. Oxygen therapy can range from temporary support during minor procedures to life-sustaining intervention for critically ill patients.

The physiological basis for oxygen therapy relates to how oxygen moves from the environment into the body's tissues. Normal room air contains approximately 21% oxygen, which is sufficient for healthy dogs with normally functioning respiratory and cardiovascular systems. However, when disease, injury, or other factors impair the lungs' ability to transfer oxygen into the blood, or when the cardiovascular system cannot deliver oxygenated blood effectively to tissues, the body's cells become starved of the oxygen they need for normal metabolism. By increasing the inspired oxygen concentration from 21% to anywhere from 40% to 100%, oxygen therapy provides a larger concentration gradient that drives more oxygen into the blood even when respiratory function is compromised.

Oxygen is delivered to canine patients through various methods depending on the severity of hypoxemia, the patient's tolerance and cooperation, and the available equipment. Common delivery methods include flow-by oxygen held near the patient's face, face masks designed for dogs, nasal cannulas or prongs inserted into the nostrils, oxygen cages or chambers that surround the patient with oxygen-enriched air, and intubation with mechanical ventilation for the most critically ill patients. Each method has advantages and limitations regarding the oxygen concentration achieved, patient comfort, and the ability to perform other treatments simultaneously. Veterinary professionals select the most appropriate delivery method based on the individual patient's needs and clinical circumstances.

While oxygen itself is one of the safest therapeutic interventions available, oxygen therapy is not without considerations and requires veterinary oversight to optimize outcomes. Prolonged exposure to very high oxygen concentrations can cause lung toxicity, making appropriate monitoring and duration management important. Some patients, particularly those with certain types of respiratory failure, require careful titration of oxygen levels to avoid complications. Additionally, oxygen therapy addresses the symptom of low blood oxygen rather than the underlying disease, making concurrent diagnosis and treatment of the primary condition essential for recovery. Oxygen is typically administered in veterinary hospital settings, though home oxygen therapy is occasionally arranged for dogs with chronic conditions under veterinary supervision.

The primary indication for oxygen therapy in dogs is hypoxemia, defined as abnormally low oxygen levels in the blood, regardless of the underlying cause. Hypoxemia may result from any condition that impairs the lungs' ability to absorb oxygen, reduces the blood's ability to carry oxygen, or decreases the delivery of oxygenated blood to tissues. Clinical signs of hypoxemia include increased respiratory rate and effort, cyanosis (blue or gray coloration of the gums and tongue), weakness, collapse, anxiety, and decreased responsiveness. Dogs exhibiting these signs benefit from supplemental oxygen while the cause of their respiratory compromise is determined and treated. Oxygen therapy can be truly life-saving in acute situations where without intervention, vital organs would suffer irreversible damage from oxygen deprivation.

Pneumonia and other lower respiratory tract infections represent common indications for oxygen therapy in dogs. When infection causes inflammation and fluid accumulation in the lungs, the lung tissue cannot effectively transfer oxygen into the bloodstream, resulting in hypoxemia despite the dog's increased breathing effort. Bacterial pneumonia, aspiration pneumonia, viral pneumonia, and fungal lung infections may all require oxygen support during the acute phase of illness. Oxygen therapy allows the dog's body to maintain adequate tissue oxygenation while antibiotics, antifungal medications, or supportive care address the underlying infection. Dogs with pneumonia may require oxygen therapy for hours to days depending on the severity of their condition.

Heart failure is another major indication for supplemental oxygen in dogs, particularly when congestive heart failure leads to fluid accumulation in or around the lungs. Dogs with dilated cardiomyopathy, degenerative valve disease, or other cardiac conditions may develop pulmonary edema (fluid in the lungs) that impairs oxygen transfer. These patients often present in severe respiratory distress and require immediate oxygen supplementation along with diuretic therapy and other cardiac medications. The oxygen support helps stabilize the patient while the cardiac medications begin to reduce the fluid overload. Some dogs with chronic heart disease may experience recurrent episodes requiring repeated oxygen therapy during acute decompensation events.

Trauma, shock, and post-surgical recovery represent additional scenarios where oxygen therapy is commonly employed. Dogs that have experienced significant trauma may have compromised breathing from chest injuries, blood loss, or shock, all of which can reduce oxygen delivery to tissues. Post-operative patients, particularly those recovering from lengthy procedures or thoracic surgery, often receive supplemental oxygen during the immediate recovery period. Anesthetic drugs typically depress respiratory function to some degree, and oxygen supplementation helps ensure adequate oxygenation until the patient is fully recovered and breathing normally. Dogs recovering from cardiopulmonary arrest receive high-flow oxygen as part of their post-resuscitation care.

Other conditions that may require oxygen therapy include airway obstruction from foreign bodies, masses, or laryngeal paralysis; severe anemia where reduced red blood cell numbers limit oxygen-carrying capacity; pulmonary thromboembolism where blood clots block pulmonary blood vessels; near-drowning incidents; smoke inhalation; heatstroke; and various toxicities affecting respiratory function. In essence, any condition that threatens adequate tissue oxygenation may benefit from supplemental oxygen as part of comprehensive treatment.

The administration of oxygen therapy in dogs involves selecting an appropriate delivery method and oxygen flow rate based on the patient's clinical condition, the severity of hypoxemia, and practical considerations regarding patient tolerance and available equipment. Unlike pharmaceuticals with specific milligram doses, oxygen therapy is titrated based on the patient's response, with the goal of achieving adequate blood oxygen levels while avoiding unnecessary exposure to very high oxygen concentrations. Veterinary professionals make ongoing adjustments to oxygen delivery based on continuous or intermittent monitoring of the patient's status.

Flow-by oxygen represents the simplest delivery method, involving holding oxygen tubing or a mask within a few inches of the patient's face without direct contact. This method provides relatively low oxygen enrichment, typically achieving inspired oxygen concentrations of 25% to 40%, but is well-tolerated by anxious or fractious patients who will not accept other delivery methods. Flow-by oxygen is commonly used for initial stabilization in the emergency room while more definitive delivery methods are arranged, and for patients who become stressed with closer application of oxygen equipment. Flow rates of 2 to 5 liters per minute are typical for flow-by delivery in dogs.

Face masks designed for veterinary patients can deliver higher oxygen concentrations than flow-by methods, typically achieving 40% to 60% inspired oxygen when properly fitted. Masks must be sized appropriately for the patient and positioned to cover the nose and mouth without causing distress. Some dogs tolerate masks well, while others find them stressful, and forcing a mask on an anxious patient may worsen respiratory distress by increasing stress and oxygen demand. Masks are useful for short-duration oxygen supplementation during procedures, transport, or stabilization. Flow rates of 5 to 10 liters per minute are common for mask delivery.

Nasal cannulas or nasal prongs provide a more secure method of oxygen delivery that allows the patient some freedom of movement. A soft tube is inserted into one or both nostrils and secured with sutures or adhesive. This method can deliver inspired oxygen concentrations of 30% to 50% with flow rates of 50 to 100 milliliters per kilogram per minute, though higher concentrations can be achieved with higher flow rates. Nasal oxygen is well-suited for patients requiring longer-term supplementation who are stable enough to have the cannula placed. Some patients tolerate nasal cannulas excellently, while others require light sedation or an Elizabethan collar to prevent removal.

Oxygen cages or chambers provide oxygen-enriched environments where the entire patient is surrounded by air with elevated oxygen content. These enclosures can achieve high inspired oxygen concentrations of 40% to 60% or higher while allowing the patient to rest without equipment on their face. Oxygen cages are particularly valuable for anxious patients, cats, and small dogs, and for patients requiring extended oxygen therapy. Drawbacks include the inability to directly monitor or treat the patient without opening the cage and losing the oxygen-enriched environment. Temperature and humidity control within the cage is also important to prevent overheating.

Intubation and mechanical ventilation represent the most intensive form of oxygen delivery, allowing complete control over inspired oxygen concentration up to 100% while also supporting or replacing the patient's breathing effort. This method is reserved for severely compromised patients who cannot maintain adequate ventilation on their own, including those under general anesthesia, those in respiratory failure, and those recovering from cardiopulmonary arrest. Mechanical ventilation requires sophisticated equipment and intensive nursing care.

Oxygen therapy is generally considered one of the safest therapeutic interventions in medicine, as oxygen is essential for life and supplementation typically causes minimal adverse effects when used appropriately. However, as with any therapy, potential complications exist, particularly with prolonged exposure to very high oxygen concentrations or in specific patient populations. Understanding these potential issues helps veterinary professionals optimize oxygen therapy to maximize benefit while minimizing risk. Most dogs receiving oxygen therapy for typical durations and at commonly used concentrations experience no adverse effects from the oxygen itself.

Oxygen toxicity represents the most significant potential complication of oxygen therapy, occurring when patients are exposed to very high oxygen concentrations for extended periods. Pulmonary oxygen toxicity can develop when inspired oxygen concentrations exceeding 60% are maintained for more than 24 to 48 hours continuously, causing damage to the lung tissue that paradoxically worsens respiratory function. The damage results from the formation of reactive oxygen species that overwhelm the body's antioxidant defenses and cause cellular injury. This complication is primarily a concern in intensive care settings where high-concentration oxygen is used for extended periods; it is not a significant risk with the shorter-duration therapy used in most clinical situations.

In certain patients with chronic respiratory disease, particularly those with chronic carbon dioxide retention, the administration of high-concentration oxygen can theoretically reduce respiratory drive through complex physiological mechanisms. This consideration applies primarily to patients with severe chronic obstructive pulmonary disease, which is uncommon in dogs. Nevertheless, veterinary professionals monitor patients receiving oxygen therapy for any signs of respiratory depression, and oxygen is titrated to the lowest concentration necessary to maintain adequate blood oxygen levels rather than routinely using the highest possible concentrations.

Drying of the airways can occur with high-flow oxygen delivery if the gas is not adequately humidified. This can cause discomfort, crusting of nasal secretions with nasal oxygen delivery, and potentially impaired mucociliary clearance that helps protect the lungs from infection. Most veterinary oxygen delivery systems incorporate humidification, and attention to this aspect of therapy helps prevent drying-related complications. Patients on long-term nasal oxygen may require periodic cleaning of the nasal passages and application of lubricant to prevent crusting.

Complications related to oxygen delivery equipment rather than oxygen itself can also occur. Nasal cannulas can cause local irritation, nasal erosion, or epistaxis (nosebleeds) if improperly positioned or left in place for extended periods. Face masks can cause pressure injury or anxiety in some patients. Oxygen cages may lead to hyperthermia if temperature is not properly controlled, particularly in brachycephalic breeds or patients with fever. Intubation and mechanical ventilation carry their own significant risks including airway trauma, ventilator-associated pneumonia, and barotrauma. Despite these considerations, the benefits of oxygen therapy in hypoxemic patients dramatically outweigh the risks, and complications are manageable with appropriate monitoring and care.

True contraindications to oxygen therapy are extremely rare, as oxygen is a fundamental requirement for life and supplementation is almost always appropriate when hypoxemia is present. The primary consideration when approaching oxygen therapy is not whether to provide oxygen but rather how best to deliver it while managing the patient's other needs. However, certain clinical scenarios require careful attention to how oxygen is administered or to concurrent patient factors that may influence the therapy approach.

Patients with severe facial trauma or nasal obstruction may not be candidates for nasal cannula oxygen delivery, requiring alternative methods such as flow-by, mask, oxygen cage, or intubation depending on their clinical status. Similarly, patients with severe facial anxiety or phobia of masks may experience worsened respiratory distress if mask oxygen is forced upon them, making oxygen cages or sedation more appropriate. The principle in oxygen delivery is that the method should help rather than harm the patient, and this sometimes requires adapting to individual patient tolerance.

Dogs with certain types of chronic respiratory failure, particularly those with severe chronic bronchitis and carbon dioxide retention, may require careful titration of oxygen therapy rather than high-concentration oxygen supplementation. In these patients, the respiratory drive may be partially dependent on relative hypoxemia, and sudden correction to high oxygen levels could theoretically reduce ventilatory effort. While this phenomenon is less well-documented in dogs than in humans, veterinary professionals typically use the lowest oxygen concentration necessary to maintain acceptable blood oxygen levels rather than maximizing inspired oxygen concentration in all patients.

Patients with bleomycin-induced lung injury or those who have received bleomycin chemotherapy may have increased susceptibility to oxygen toxicity and should receive the lowest effective oxygen concentration. This specific consideration relates to the mechanism of bleomycin toxicity, which involves oxidative lung damage that can be exacerbated by high oxygen concentrations. Dogs receiving or having received bleomycin for cancer treatment should have this history noted, and oxygen therapy should be carefully managed if required.

Flammability considerations represent an environmental rather than patient contraindication. While oxygen itself is not flammable, it supports combustion and can cause fires to burn more intensely. Oxygen therapy areas must be free of open flames, sparks, and smoking materials. Electrical equipment used near oxygen delivery systems should be spark-free. These precautions are standard in veterinary hospitals but are worth noting for any situations where oxygen might be used outside typical clinical environments.

Oxygen therapy has a unique position among therapeutic interventions in that it does not interact with other medications in the traditional pharmacological sense. As a supportive therapy rather than a drug that enters the bloodstream and affects biochemical pathways, oxygen supplementation can generally be provided safely alongside any other medications the patient may be receiving. This compatibility makes oxygen therapy an excellent foundational treatment that can be maintained while other therapies are initiated and adjusted. Nevertheless, certain considerations regarding concurrent treatments are relevant for optimizing patient care.

Bleomycin, a chemotherapy agent occasionally used in veterinary oncology, has the unique property of causing oxidative lung damage that can be exacerbated by high oxygen concentrations. While this is not a drug interaction in the classical sense, the combined effect of bleomycin and oxygen on lung tissue is clinically significant. Patients who have received bleomycin should have this noted in their medical records, and if oxygen therapy is needed, the lowest effective concentration should be used with careful monitoring for any signs of respiratory deterioration. This consideration may remain relevant for months to years after bleomycin administration.

Vasodilator medications used in the treatment of pulmonary hypertension or heart failure may have their effects influenced by oxygen therapy, as oxygen itself has pulmonary vasodilating properties. The combination is generally beneficial, as both oxygen and pulmonary vasodilators work to reduce pulmonary vascular resistance and improve blood flow through the lungs. However, veterinary professionals managing patients on these medications should be aware that changes in oxygen supplementation may affect the patient's hemodynamic status and may necessitate adjustment of vasodilator doses as the patient's condition changes.

Anesthetic agents and sedatives frequently accompany oxygen therapy, as many patients receiving supplemental oxygen are either undergoing anesthesia or require sedation for diagnostic procedures or management of anxiety. These drugs typically cause some degree of respiratory depression, which is one reason why oxygen supplementation is standard during anesthesia. The combination of sedatives with oxygen delivery is routine and safe, but patients should be monitored for adequate ventilation as well as oxygenation, as supplemental oxygen can mask the development of hypoventilation by maintaining blood oxygen levels even when breathing is depressed.

Bronchodilators, corticosteroids, diuretics, and other medications commonly used in patients with respiratory disease are all compatible with concurrent oxygen therapy. In fact, these medications often work synergistically with oxygen to improve the patient's respiratory status, with bronchodilators opening airways, steroids reducing inflammation, and diuretics clearing fluid from the lungs while oxygen supplementation maintains tissue oxygenation during recovery. The comprehensive treatment of respiratory disease typically involves oxygen therapy as one component of a multi-modal approach.

General precautions for oxygen therapy in dogs center on appropriate patient monitoring, proper equipment use, and environmental safety. While oxygen therapy itself is extremely safe, the clinical situations requiring oxygen supplementation are often serious, and patients receiving oxygen therapy require vigilant observation for changes in their condition. The delivery of oxygen should be seen as one component of comprehensive patient care rather than a standalone treatment, with attention to diagnosis and treatment of the underlying cause of hypoxemia remaining paramount.

Monitoring during oxygen therapy ideally includes measurement of blood oxygen levels through pulse oximetry or arterial blood gas analysis. Pulse oximetry provides non-invasive, continuous monitoring of blood oxygen saturation and is the most practical method for ongoing assessment in most clinical situations. Target oxygen saturation levels are typically above 94% to 95%, though specific goals may vary based on the patient's condition and the underlying disease. Visual assessment of respiratory rate and effort, mucous membrane color, and patient demeanor provides important supplementary information. Patients whose condition does not improve or deteriorates despite oxygen therapy require urgent evaluation for treatable causes.

Temperature management is particularly important for patients in oxygen cages or chambers, as these enclosed spaces can become warm, leading to hyperthermia, especially in patients with compromised thermoregulation or in brachycephalic breeds. Oxygen cages should have temperature and humidity controls, and patients should be monitored regularly for signs of overheating including panting, restlessness, and elevated body temperature. If necessary, cooling measures should be implemented or alternative oxygen delivery methods used.

Brachycephalic breeds such as Bulldogs, French Bulldogs, Pugs, and Boston Terriers deserve particular consideration during oxygen therapy. These breeds have inherent respiratory compromise due to their shortened airways and may be more likely to require oxygen supplementation during stress, heat exposure, or illness. They are also more prone to overheating, particularly in enclosed oxygen cages. Face mask and flow-by oxygen may be less efficient in brachycephalic dogs due to their facial anatomy. Despite these challenges, brachycephalic dogs benefit from oxygen therapy when hypoxemic and should receive appropriate supplementation with attention to their breed-specific needs.

Fire safety precautions are essential in areas where oxygen is used or stored. Oxygen supports combustion and can cause fires to burn more intensely and spread more rapidly. No open flames, smoking materials, or spark-producing equipment should be permitted in oxygen therapy areas. Petroleum-based products should not be used on equipment or patients receiving oxygen, as these can ignite in oxygen-enriched environments. Staff should be trained in oxygen safety, and appropriate fire extinguishing equipment should be readily available.

Storage and handling of oxygen in veterinary facilities requires attention to safety regulations, equipment maintenance, and proper procedures to ensure both safe operation and reliable availability when needed. Oxygen for medical use may be supplied as compressed gas in cylinders, as liquid oxygen in specialized containers, or generated on-site by oxygen concentrators. Each supply method has specific storage and handling requirements that must be followed to maintain safety and ensure the oxygen remains suitable for medical use.

Compressed oxygen cylinders are the most common form of oxygen supply in many veterinary practices. These cylinders contain oxygen at very high pressure and must be handled with care to prevent damage that could cause rupture or rapid gas release. Cylinders should be stored upright and secured to prevent falling, either with chains, straps, or in appropriate cylinder stands. Storage areas should be well-ventilated and away from heat sources, flames, and combustible materials. Cylinders should be checked regularly for damage, corrosion, or expired testing dates, and any damaged cylinders should be removed from service. Separate storage of full and empty cylinders helps maintain organized inventory management.

Oxygen concentrators are devices that extract oxygen from room air, concentrating it to therapeutic levels for patient delivery. These units require electrical power and regular maintenance according to manufacturer specifications. Filters should be cleaned or replaced on schedule, and the unit's output should be periodically verified to ensure adequate oxygen concentration is being delivered. Concentrators offer the advantage of continuous oxygen supply without the need for cylinder changes, making them valuable for facilities with high oxygen use or for home oxygen therapy situations.

Liquid oxygen systems are used in some larger veterinary hospitals and provide a continuous supply of oxygen that is converted to gas as needed. These systems require specialized installation and maintenance by qualified personnel. Liquid oxygen containers must be handled carefully due to the extremely cold temperatures involved, which can cause cryogenic burns on contact. Proper training is essential for staff who handle liquid oxygen systems.

General safety practices for all oxygen systems include keeping oxygen equipment and supply areas free of oil, grease, and combustible materials. Connections should be tightened using appropriate wrenches, never forced, and should be checked for leaks regularly. Only equipment designed for use with oxygen should be connected to oxygen supplies. Staff should be trained in emergency procedures in case of oxygen system fires or malfunctions. Documentation of oxygen inventory, inspections, and any incidents should be maintained as required by facility protocols and regulatory requirements.

Oxygen therapy can be provided to dogs of all breeds when clinically indicated, with delivery method and monitoring adjusted based on breed-specific anatomical and physiological characteristics. While the oxygen itself is beneficial regardless of breed, certain breeds present unique considerations that influence how oxygen therapy is best delivered and monitored. Understanding these breed-related factors helps veterinary professionals optimize care for individual patients.

Brachycephalic breeds including Bulldogs, French Bulldogs, Pugs, Boston Terriers, Pekingese, and Shih Tzus have respiratory anatomy that predisposes them to breathing difficulties and may increase their need for oxygen supplementation during illness, stress, or anesthesia. These breeds have elongated soft palates, stenotic nares (narrowed nostrils), hypoplastic tracheas, and other abnormalities that compromise airflow even under normal conditions. When these dogs become hypoxemic, they may deteriorate rapidly, making prompt oxygen supplementation particularly critical. However, their facial anatomy can make mask oxygen delivery less efficient, and they are more prone to overheating in enclosed oxygen cages due to their already compromised ability to thermoregulate through panting. Flow-by oxygen or nasal cannulas may be preferred delivery methods in some brachycephalic patients.

Giant breeds such as Great Danes, Irish Wolfhounds, Mastiffs, and Saint Bernards may present practical challenges related to their size. Oxygen cages designed for smaller patients may not accommodate these large dogs, necessitating alternative delivery methods such as nasal cannulas, masks, or tent-style oxygen enclosures. The higher tidal volumes and oxygen consumption of giant breeds may require higher flow rates to achieve target oxygen concentrations. Despite these logistical considerations, giant breeds respond to oxygen therapy just as effectively as smaller dogs when appropriately treated.

Toy and small breeds including Chihuahuas, Yorkshire Terriers, Pomeranians, and similar dogs can be easily accommodated in standard oxygen cages and often tolerate this delivery method well. Their small size makes even small-volume oxygen cages effective for creating oxygen-enriched environments. However, these small patients may be more susceptible to temperature changes within enclosed spaces and should be monitored for both hypothermia and hyperthermia. Nasal cannulas in very small patients require appropriately sized equipment and careful placement to avoid obstruction.

Age-related considerations apply across all breeds, with neonatal puppies and geriatric dogs potentially requiring special attention during oxygen therapy. Neonatal puppies have high oxygen demands relative to their size and may develop hypothermia quickly if not kept warm during oxygen administration. Geriatric dogs may have concurrent cardiovascular or respiratory disease that influences their oxygen therapy needs and response. Dogs with breed-specific predispositions to heart disease, such as Cavalier King Charles Spaniels with mitral valve disease, may require oxygen therapy during cardiac decompensation episodes.

Oxygen therapy is often used alongside various medications that address the underlying causes of respiratory compromise or support recovery from hypoxemia. Understanding the medications commonly used with oxygen therapy helps provide context for the comprehensive management of dogs with respiratory distress. Pet owners should work closely with their veterinarian to understand all aspects of their dog's treatment plan.

Diuretics, particularly furosemide, are commonly administered alongside oxygen therapy in dogs with pulmonary edema from congestive heart failure. The oxygen maintains tissue oxygenation while the diuretic helps remove excess fluid from the lungs, improving the lungs' ability to absorb oxygen. This combination is foundational in the emergency treatment of dogs presenting in cardiogenic pulmonary edema. Other cardiac medications including pimobendan, enalapril, and spironolactone may be initiated or continued during hospitalization with oxygen support.

Bronchodilators such as terbutaline, aminophylline, or albuterol may be used in conjunction with oxygen therapy in dogs with bronchospasm, asthma-like conditions, or chronic bronchitis. These medications help open constricted airways, improving airflow and the distribution of supplemental oxygen throughout the lungs. Bronchodilators may be administered systemically or via nebulization depending on the clinical situation. Oxygen therapy supports the patient while bronchodilators take effect and helps ensure adequate oxygenation even when airway disease limits ventilation.

Corticosteroids including prednisone, prednisolone, and dexamethasone are often used in patients receiving oxygen therapy when inflammation contributes to respiratory compromise. Conditions such as allergic airway disease, immune-mediated hemolytic anemia with pulmonary thromboembolism, or inflammatory lung disease may require corticosteroid therapy alongside oxygen support. The steroids work to reduce inflammation over hours to days while oxygen therapy provides immediate life support.

Antibiotics are essential concurrent therapy when bacterial infection causes or contributes to respiratory disease requiring oxygen support. Dogs with bacterial pneumonia, infected pleural effusion, or secondary infections complicating other respiratory conditions receive appropriate antimicrobial therapy while oxygen supplementation maintains adequate oxygenation. The choice of antibiotic depends on the suspected or confirmed pathogens and may be adjusted based on culture and sensitivity results. Supportive care including intravenous fluids, nutritional support, and nebulization therapy may also accompany oxygen and antibiotic treatment in hospitalized patients.